ArticleClinical case reports2025
Successful Right Sided Subcutaneous Implantable Cardioverter-Defibrillator Implantation in Situs Inversus Dextrocardia: A Case Report and Literature Review.
Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case report details the successful implantation of a subcutaneous implantable cardioverter-defibrillator (S-ICD) in a 70-year-old male with situs inversus dextrocardia, a rare congenital condition where the heart and visceral organs are reversed. The patient, with a history of ischemic heart disease and severe left ventricular dysfunction (ejection fraction 25%), required primary prevention of sudden cardiac death. Due to anatomical challenges with transvenous ICD placement and no need for pacing or resynchronization, an S-ICD was selected. Pre-procedural screening was modified by reversing electrode positions to accommodate the right-sided heart, ensuring eligibility across all sensing vectors. The S-ICD was implanted using a two-incision technique, positioning the generator in the right midaxillary line and the electrode along the left parasternal area. Defibrillation threshold testing confirmed effective termination of induced ventricular fibrillation with a 60 J shock. No complications occurred, and 1-month follow-up verified normal device function. This case demonstrates the adaptability and safety of S-ICD implantation in dextrocardia, emphasizing tailored screening and procedural adjustments. A review of existing literature shows consistent success with S-ICDs in similar patients, though device placement varies. This report adds to the evidence supporting S-ICD use in complex congenital anatomies, providing valuable guidance for clinicians.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.